TCL Archive In Brief: More Money, Not Reorganization, Is Needed For Clinical Research, Paul Carbone Argues November 10, 1978
TCL Archive FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says. January 14, 2005
